Berkshire Hathaway 1Q Results Top Street View
Warren Buffett's Berkshire Hathaway revealed 1Q earnings that easily beat expectations on both the top and bottom lines.
Ratings Growth Carries McGraw-Hill to 1Q Beat
McGraw-Hill beat Street views, as the company benefited from a large gain tied to the sale of its education business.
Markets Yawn at Morgan Stanley's 1Q EPS Beat
Shares of the investment bank retreated despite posting adjusted results that exceeded forecasts.
Mixed Verdict: American Express 1Q EPS Tops Views, Revenue Disappoints
American Express unveiled a stronger than expected 2% rise in profits despite a "slow growth economy," but the card giant's revenue grew less than hoped.
Investment Banking Carries Goldman Sachs to 1Q Beat
The Wall Street titan's results exceeded expectations thanks to solid investment-banking growth.
BlackRock Logs 10% Jump in 1Q Net, Exceeds Estimates
The New-York based company posted a 10% jump in net income as investors increasingly turned to the money manager's higher-fee stock funds.
Sales Growth Lifts Sherwin-Williams 3Q Profit
Sherwin-Williams reported a 12% increase in its third-quarter earnings, led by a big sales boost at the company’s paint stores.
AstraZeneca Sees 2016 Earnings Falling
AstraZeneca warned that revenue and earnings would drop this year due to the arrival of cheap generic rivals to its cholesterol fighter Crestor.
Bristol-Myers Forecasts '16 Profit Above Estimates
Bristol-Myers Squibb forecast 2016 earnings slightly above Wall Street estimates.
Amgen Boosts Outlook as Profit Rises 50%
Amgen Inc. raised its 2015 guidance as the biotechnology company reported that its third-quarter earnings rose 50% on stronger revenue led by Enbrel and other key drugs.
Gilead 2Q Profit Beats Wall Street, 2015 Sales Outlook Raised
Gilead Sciences Inc said on Tuesday its quarterly net profit rose 32 percent, driven by sales of hepatitis C drugs that beat Wall Street estimates.
Merck Misses Estimates in 4Q; Plans Increased Focus on Cancer
Merck posted weaker-than-expected sales amid stronger competition from generic medicines, while the pharma heavyweight posted a full-year profit view that bracketed the Street's view.
Pfizer Tops 4Q Views on New Treatments, Emerging Markets
Pfizer reported better-than-expected fourth-quarter results, helped by sales of new treatments for cancer, nerve pain and arthritis.
Oncology Drugs Give Pfizer 3Q Boost
Pfizer reported better-than-expected third-quarter earnings helped by cost cuts and growing sales of recently approved cancer medicines.
Lagging Pacemaker Sales Don't Derail St. Jude in 3Q
The medical device maker reported improved earnings in the third quarter despite lagging sales of pacemakers and backed its full-year outlook.
CVS Fills More Prescriptions, Bests Street in 2Q
CVS Caremark's 2Q profit rose slightly more than expected, as profit growth at the pharmacy benefits management unit helped buoy modest improvements at the drugstores.
Weight Watchers Beats 3Q Profit Forecasts
Weight Watchers International Inc. (NYSE:WTW) on Thursday reported third-quarter net income of $21.8 million.
AIG Profit Lifted by AerCap, China Investment; Raises Buyback
Insurer American International Group Inc (NYSE:AIG) reported a 5.6 percent jump in quarterly operating profit, driven by investments in one of China's biggest insurers and earnings from aircraft leasing company AerCap.
Aetna 1Q Tops Expectations as Membership Grows, Raises Year View
The health insurer's first-quarter earnings fell 4.1%, partly due to integration and other charges, while its revenue and membership rolls increased.
Humana Sees Membership Growth Despite Funding Cuts
The insurer expects to grow its Medicare Advantage plans in 2014 despite government funding cuts, however it merely reaffirmed a full-year outlook that is slightly below expectations.


















